Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Boehringer Ingelheim sees production plant inaugurated

Boehringer Ingelheim sees production plant inaugurated

30th November 2007

An expanded and modernised biopharmaceutical production plant at Boehringer Ingelheim’s Research & Development and Biotechnology site in Biberach, Germany, was inaugurated today.

A total of 80 million euros (57 million pounds) has been invested into the modernisation and expansion of the plant since the project was started in 2005.

The plant now joins another fully redeveloped production facility for active pharmaceutical ingredients on the Biberach site, with the company stating that the overall modernisation has strengthened its expertise in biotechnology.

“We have thus achieved a clear competitive advantage – which not only benefits our own company but also our customers – in order to ultimately ensure our company’s goal that patients around the world will continue to receive innovative medications,” said Dr Hans-Jurgen Leuchs, head of corporate board division operations.

Dr Uwe Bucheler, senior vice-president of the biopharmaceuticals division, illustrated that the expansion of the production plant was necessary as the facility approached its capacity limits.

Starting operation in 1986 the Biberach facility was the first large-scale plant of its kind in Europe, according to Dr Bucheler.

Earlier this year, Boehringer Ingelheim beat off a number of competitors to be named as the top employer in the pharmaceutical and biopharmaceutical industry according to Science magazine.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.